Mad Money W/ Jim Cramer

Jim Cramer’s been at this game for a long time, and tonight he’s taking his accumulated wisdom and laying it out in his rules for managing your own money. From stock picking to understanding dividends, this show is all about taking a peak behind the curtain so you can grow your wealth just like the pros. 

Jim Cramer knows that sometimes it’s important to pull away from the madness of Wall Street and just understand the basics. Tonight, Cramer’s giving you his economics playbook to make sure you understand the market on a whole new level. This is a modern day economics lesson that you can‘t afford to miss! 

The American education system has taught you chemistry, geometry, and physics, but what about financial literacy? Tonight, Jim Cramer’s giving you his playbook for managing a financially-stable life. From contributing to a 401k to understanding the many different funds that the market offers, this show is all about demystifying a world that is often not taught in school. It may be winter break, but class is in session and Professor Cramer is ready to help you navigate any financial confusion you may have.  

The Dow closed up 78 points today and Jim Cramer’s revealing 12 things that he wants from the market going into the new year. And, don’t be a pig- Arrowhead Pharma and InMode have rallied recently, and Cramer’s teaching a lesson about when to take profits. Then, the CEO of Paychex, Marty Mucci, is here to talk about the company’s recent earnings and where the stock is headed into the new year. Also, take out your notebook, because Cramer’s turning in his homework on Allakos and Global Blood Therapeutics.

The Dow skyrocketed 138 points today and Jim Cramer’s breaking down today’s rally, with the Dow, S&P, and Nasdaq breaking all-time highs. Then, it was the year of the IPO, but which one’s deserve Cramer’s praise now that we’re heading into 2020? And, CEO of Emergent BioSolutions Robert Kramer sits down with Cramer to talk about the company’s growth, new acquisitions, and a 40% rally from its lows in August. Plus, Sudheesh Nair, CEO of ThoughtSpot, discusses where what the private start-up’s mission could mean for the data analytics industry.

The Dow closed down today 28 points and Jim Cramer’s looking at today’s action and updating you on what the impeachment vote means for your money. Then, Cramer’s breaking down how the markets moved in 1998 and 1999 when former President Bill Clinton was impeached and how curtained stocks fared while everyone watched what was going on in Washington. And, huddle up- Cramer’s digging into FedEx’s disappointing earnings call today and what’s in store for the stock going forward.

The Dow closed up 31 points hitting another all-time high and Cramer’s digging into today’s biggest movers. Then, the drug companies have been caught in political crosshairs, and Cramer’s getting to the core of it with Eli Lilly’s CEO. And, with the market at all-time highs, are there any bargains out there? Cramer’s going off the charts to look at bargain buys during market highs. And you’ve called in and stumped Professor Cramer, and tonight he’s turning in his homework on Wave Life Sciences and sharing what lessons he has learned through his research into speculative biotech names. 

The Dow closed up 101 points with all three major indices hitting record highs and Jim Cramer’s breaking down today’s headlines. Then, S&P Global has had a powerful year, so what should you make of the company behind the benchmark index? Cramer’s sitting down with the company’s CEO to discuss its latest acquisitions and newest products. And, last week Bill.com hit the tape and immediately surged 69% higher, and Cramer’s digging into this new IPO and seeing if this was the listing that the 2019 IPO market needed to end the year on a high note. Plus, Cramer’s sitting down with Livongo Health’s founder and executive chairman to make sense of this recent IPO and the volatility the stock has experienced since hitting the public market. 

Despite a phase one trade deal with China, the Dow remained steady today, rising only 3 points, and Jim Cramer’s giving you his Game Plan to navigate next week on Wall Street. Then, Anaplan CEO Frank Calderoni sits down to talk about the stock’s recent roar, up 90% for the year, and where the company is headed from here. Then, Dr. Vlad Coric, CEO of Biohaven Pharmaceuticals is in the Mad Money studio to talk about what’s in the company’s pipeline and what it means for the company’s future. And, what should you make of the managed care company’s heading into 2020? Cramer’s talking with Centene’s CEO, Michael Neidorff, to discuss the stock’s recent decline how you should interpret the company’s new guidance and its acquisition of WellCare.

The Dow closed up 221 points on reports that a phase one US/China trade deal has been reached and Cramer’s revealing some stocks that you should continue to watch in the midst of trade deal headlines. Then, fresh off earnings Cramer’s talking with Adobe’s CEO to see if this cloud king can continue to reign on. And, Robinhood’s Co-CEOs joined Cramer last week, but the news keeps coming with this disruptor. Co-CEO Vlad Tenev is back to discuss the company’s latest feature, fractional share trading. Plus, after New Relic’s latest report could the company’s recent action be the start of a rebound or should you continue to be cautious? Cramer’s checking in with the company’s founder and CEO to make sense of the stock’s performance. 

The Dow closed up 30 points and Jim Cramer’s pinning two battleground stocks against each other, Tesla and Netflix, to see what separates these talked about companies. Then, VMWare’s stock has struggled lately, so has the it finally reached a bottom? Cramer’s checking in with the COO of one of his Cloud Kings. And, Palo Alto Networks seemed to disappoint Wall Street, so what should you make of the company’s recent performance? Cramer’s checking in with the company’s CEO. Plus, Trade Desk has rallied over 100% this year, but is now the time to trade into the stock? Cramer’s joined by the Founder and CEO to make sense of the stock’s run. 

The Dow closed down for a second day posting a 28-point decline and Jim Cramer’s sharing what buying opportunities he’s seeing in this market. Then, could the tariffs remain a threat for YETI’s future? Cramer’s taking a look at this fresh-faced stock and if he believes YETI can keep on roaring. And, Cramer’s going Off the Charts to dig into a few sectors that could have more upside in 2020. Plus, everyone is always asking Cramer, “how do you play the trade talks?” Cramer’s giving his strategy for navigating the influx of headlines. 

The Dow closed down 105 points and Cramer’s digging into what impacted today’s tape. Then, Nutanix is shifting its business model and with that is coming volatility in the stock. Cramer’s checking in with Nutanix’s founder and CEO to make sense of the company’s plans for the future. And, there are clear bull and bear cases when it comes to AT&T, and Cramer’s looking at both sides to see which he thinks holds more weight. Plus, Cramer’s been polling you on Twitter to see how you shop, so what should you make of the conflicting stories in the department store cohort? Cramer’s giving his take on what these retailers can’t seem to get right. 

The Dow finished the week soaring 337 points higher and Jim Cramer’s breaking down today’s market moves and giving you his Game Plan for next week’s action. Then, Mad Money saddles up for Jim Conroy, CEO of BootBarn, to visit the studio to discuss the company’s impressive third quarter results and what’s in store for the footwear retailer going forward. Then, could it be time to check into Grocery Outlet? CEO Eric Lindberg sits down with Cramer to weigh in on the discount food retailer’s recent IPO and whether or not you should add it to your portfolio. And, CEO of diagnostics company Natera, Steve Chapman, is here to breakdown the company’s fundamentals, impressive third quarter results and where the company’s headed.

The Dow jumped 28 points today and Jim Cramer’s making sense of today’s up and down action. Then, Edwards Lifesciences’ CEO, Mike Mussallem makes his way to the Mad Money studio straight from the company’s investor conference and he’s digging into the company’s pipeline and what’s on the horizon. And, Cramer’s sitting down with ServiceNow’s new CEO, Bill McDermott, to discuss his future plans for the cloud computing company. Plus, Cramer’s talking with Chipotle’s CEO and CFO, Brian Niccol and Jack Hartung, from a store in NYC to discuss the stock’s monster run and learn the secret ingredients behind the company’s success. 

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box,” anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer. Listen in to today’s episode and subscribe to the podcast.Hedge fund manager Kyle Bass says China gets too much in loans from the global community. Rep. Anthony Gonzalez (R-OH) has introduced a bill, the Accountability for World Bank Loans to China Act, to make China graduate from the program that lends money to developing countries. Gonzalez tells Becky Quick, Joe Kernen and guest host Tom Farley that China’s economy is too big to qualify. CVS Health CEO Larry Merlo lays out how the company has changed one year after its Aetna acquisition and how it will play a role in healthcare

The Dow snapped a three-day losing streak gaining 147 points and Cramer’s digging into today’s headlines. Then, Robinhood has changed the face of investing, and Cramer’s sitting down with the company’s co-founders & co-CEOs to learn more about how Robinhood is disrupting the industry. Then, just ahead of the holiday’s Cramer’s talking to Mattel’s CEO to learn more about holiday shopping and the release of the infamous “Baby Yoda”. Plus, Cramer’s sitting down with an under the radar biotechnology company, AVITA Medical, to learn more about their revolutionary procedures and the stock’s recent run. 

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box,” anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer. Listen in to today’s episode and subscribe to the podcast.Billionaire investor, Home Depot co-founder Ken Langone joined Squawk Box to discuss President Trump’s U.S.-China trade war strategy, the education system and the Fed. Ryan Lance, Chairman and CEO of energy giant ConocoPhillips has a ten year plan to sustain the company—and its shareholders—through market volatility and geopolitical uncertainty. Plus, Google CEO Sundar Pichai got a promotion; he’s now CEO of parent company Alphabet as the two original founders step aside.

The Dow fell 280 points and Cramer’s breaking down how today’s headlines contributed to the market sell-off. Then, does PPG have more room to run in this market? Jim Cramer is painting a clearer picture with CEO, Michael McGarry, to get a better sense of where the company is going next. And, Coupa Software beat earnings expectations, but the cloud-based company’s report didn’t seem to make it to investors nice list. Cramer’s getting to the bottom of the stock’s recent performance. Plus, fresh off earnings, Cramer’s sitting down with Salesforce’s Co-CEO, Keith Block, to dig into the company’s latest report and make sense of the post-earnings reaction.

The Dow fell 268 points today and Jim Cramer is digging into the cause of Wall Street’s volatile day. Then, it’s CyberArk Monday in the Mad Money studio, and Udi Mokady, the co-founder, chairman and CEO sits down with Cramer to talk about the future of cyber security and whether this software stock can keep climbing. And, eHealth’s CEO Scott Flanders is here to discuss what his company is all about and its recent red-hot run. Plus, Cramer’s going Off The Charts to dig into the VIX and see if investors should be worried about a turn from bull to bear territory in the next few months.